Showing results (71-80 of 143) with videos related to
Sort By:
Pageof 15
Haematologica|July 21, 2018
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL groupLionel Adès, Xavier Thomas, Agnes Guerci Bresler, et al.Cancer Medicine|February 24, 2024
Dismal outcome of refractory or relapsing patients with myelodysplasia-related acute myeloid leukemia partially alleviated by intensive chemotherapyHarmony Leroy, Noémie Gadaud, Emilie Bérard, et al.Cancers|January 8, 2020
Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex KaryotypeLaurène Fenwarth, Nicolas Duployez, Xavier Thomas, et al.American Journal of Hematology|August 23, 2012
Role of autologous hematopoietic stem cell transplantation according to the NPM1/FLT3-ITD molecular status for cytogenetically normal AML patients: a GOELAMS studyRomain Guièze, Pascale Cornillet-Lefebvre, Bruno Lioure, et al.Cancers|July 30, 2020
Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry StudyPierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.Annals of Hematology|January 25, 2024
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective studyLudovic Gabellier, Pierre Peterlin, Sylvain Thepot, et al.Blood|October 26, 2006
Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 studyAdrienne de Labarthe, Philippe Rousselot, Françoise Huguet-Rigal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia GroupLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.Blood|March 22, 2003
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML IntergroupJacques Delaunay, Norbert Vey, Thierry Leblanc, et al.American Journal of Hematology|April 9, 2013
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patientsLionel Adès, Sylvie Chevret, Emmanuel Raffoux, et al.Pageof 15